Salmeterol/fluticasone propionate (50500 μg) in combination in a Diskus® inhaler (Seretide®) is effective and safe in the treatment of steroid-dependent asthma

This publication has 17 references indexed in Scilit:

• Salmeterol/Fluticasone Combination Inhaler
  Clinical Drug Investigation, 1998
• Comparative Pharmacology of Salmeterol and Formoterol and their Interaction with Salbutamol in Healthy Volunteers
  Clinical Drug Investigation, 1997
• Safety and appropriate use of salmeterol in the treatment of asthma
  Journal of Allergy and Clinical Immunology, 1996
• Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids.
  American Journal of Respiratory and Critical Care Medicine, 1996
• Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid
  The Lancet, 1994
• A Comparison of Salmeterol with Albuterol in the Treatment of Mild-to-Moderate Asthma
  New England Journal of Medicine, 1992
• Inhaled salmeterol in the treatment of patients with moderate to severe reversible obstructive airways disease — a 3-month comparison of the efficacy and safety of twice-daily salmeterol (100 μg) with salmeterol (50 μg)
  Respiratory Medicine, 1992
• Measuring compliance with inhaled medication in asthma.
  Archives of Disease in Childhood, 1992
• Salmeterol Xinafoate
  Drugs, 1991
• Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients.
  Thorax, 1988